GMO Beyond China ETF
BCHI
3 hedge funds and large institutions have $1.18M invested in GMO Beyond China ETF in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
4.34% less ownership
Funds ownership: 14.65% → 10.31% (-4.3%)
25% less funds holding
Funds holding: 4 → 3 (-1)
27% less capital invested
Capital invested by funds: $1.6M → $1.18M (-$426K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HC
Hara Capital
Bellevue,
Washington
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$492K |
BCHI Hedge Fund Activity: Q3 2025 in Review
3 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in GMO Beyond China ETF (BCHI) for Q3 2025, worth a combined $1.18M — down 27% from $1.6M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BCHI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Hara Capital, adding an estimated $17.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $492K sold.
- 3 institutional investors held GMO Beyond China ETF (BCHI) as of Q3 2025, down from 4 in Q2 2025.
- Funds reported $1.18M of GMO Beyond China ETF stock for Q3 2025, down 27% quarter-over-quarter.
- 0 funds opened new GMO Beyond China ETF positions in Q3 2025 and 1 closed out, a net change of -1 holder.
- The largest GMO Beyond China ETF buyer in Q3 2025 was Hara Capital, an estimated $17.4K added.
- The largest GMO Beyond China ETF seller in Q3 2025 was Citadel Advisors, an estimated $492K sold.
Based on aggregated 13F filings for Q3 2025.